Who owns COLLEGIUM PHARMACEUTICAL, INC (COLL)? Elite investor 13F holders
5 tracked elite investors reported holding COLLEGIUM PHARMACEUTICAL, INC as of 2026-06-30, including Renaissance Technologies LLC, Rubric Capital, D.E. Shaw, Third Avenue Management, Gotham Asset Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.
5 tracked investors currently reported holding · Latest report period: 2026-06-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, engages in the development and commercialization of medicines for pain management. The company's portfolio includes Jornay PM, a central nervous system stimulant prescription medicine that contains methylphenidate HCl for the treatment of attention deficit hyperactivity disorder; Belbuca, a buccal film that contains buprenorphine…
Reported holders and securities, including exits (up to 20)
| Investor | Security | Instrument | Report period | Filed | Value | Quantity | Units | Change | Source |
|---|---|---|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | COLLEGIUM PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-13 00:00:00 | 49469074.00 USD | 1366549.000000 | Shares | reduce | Original filing |
| Rubric Capital | COLLEGIUM PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 46321918.00 USD | 1279611.000000 | Shares | hold | Original filing |
| D.E. Shaw | COLLEGIUM PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 12249465.00 USD | 338383.000000 | Shares | reduce | Original filing |
| Third Avenue Management | COLLEGIUM PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-12 00:00:00 | 6611749.00 USD | 182645.000000 | Shares | add | Original filing |
| Gotham Asset Management | COLLEGIUM PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 2767164.00 USD | 76441.000000 | Shares | add | Original filing |
| Tudor Investment | COLLEGIUM PHARMACEUTICAL INC | SHARE | 2026-06-30 | 2026-08-14 00:00:00 | 0.00 USD | 0.000000 | Shares | exited | Original filing |
Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.
This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.